Sputnik V is over 95% efficient, Claims Russia
Image Credit: Shortpedia
Russia on Tuesday claimed 95 efficiency of its COVID-19 Vaccine Sputnik V. Meanwhile, the second interim analysis of the clinical trial of Russian COVID-19 vaccine showed a 91.4% efficacy on day 28 after the first dose. Russia said that the vaccine was over 95% efficient after 42 days of the first dose. Russia also claimed that Sputnik V against COVID-19 would cost governments much lower than that of Pfizer's and Moderna's.